• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白A-I作为无脂蛋白质或盘状及球状重组高密度脂蛋白成分的代谢:野生型和肝脂肪酶转基因兔的研究

Metabolism of apoA-I as lipid-free protein or as component of discoidal and spherical reconstituted HDLs: studies in wild-type and hepatic lipase transgenic rabbits.

作者信息

Kee Patrick, Rye Kerry-Anne, Taylor John L, Barrett P Hugh R, Barter Philip J

机构信息

University Department of Medicine, Royal Adelaide Hospital, Adelaide, Australia.

出版信息

Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1912-7. doi: 10.1161/01.atv.0000038485.94020.7f.

DOI:10.1161/01.atv.0000038485.94020.7f
PMID:12426224
Abstract

OBJECTIVE

Apolipoprotein (apo)A-I exists in 3 forms in plasma: as lipid-free apoA-I, as a component of pre-beta-migrating discoidal high density lipoproteins (HDLs), and as a component of alpha-migrating spherical HDLs. This study investigates (1) the in vivo metabolism of apoA-I in each of these forms and (2) the effects of hepatic lipase (HL) on apoA-I metabolism.

METHODS AND RESULTS

Wild-type and HL transgenic rabbits were studied. When lipid-free (125)I-apoA-I and 125I-apoA-I in pre-beta-migrating discoidal reconstituted HDLs (rHDLs) were injected into wild-type rabbits, the label rapidly appeared in alpha-migrating particles and decayed with the same fractional catabolic rate (FCR) as when they were injected as a component of spherical rHDLs. Spherical rHDLs did not change in size when they were injected into wild-type rabbits but were reduced in size in HL transgenic rabbits. The FCR of apoA-I in HL transgenic rabbits was double that in wild-type rabbits.

CONCLUSIONS

In vivo, (1) lipid-free apoA-I rapidly incorporates into preexisting alpha-migrating particles, (2) pre-beta-migrating discoidal HDLs are rapidly converted into alpha-migrating HDLs, (3) the FCR of apoA-I is independent of the form in which it is introduced into plasma, and (4) HL reduces the size of alpha-migrating HDLs and increases the rate of catabolism of apoA-I.

摘要

目的

载脂蛋白(apo)A-I 在血浆中以 3 种形式存在:无脂 apoA-I、前β迁移盘状高密度脂蛋白(HDL)的组成成分以及α迁移球状 HDL 的组成成分。本研究调查了(1)每种形式的 apoA-I 在体内的代谢情况以及(2)肝脂酶(HL)对 apoA-I 代谢的影响。

方法与结果

对野生型和 HL 转基因兔进行了研究。将无脂的(125)I-apoA-I 和前β迁移盘状重组 HDL(rHDL)中的 125I-apoA-I 注射到野生型兔体内时,标记物迅速出现在α迁移颗粒中,并以与作为球状 rHDL 的组成成分注射时相同的分数分解代谢率(FCR)衰减。将球状 rHDL 注射到野生型兔体内时其大小不变,但在 HL 转基因兔体内其大小减小。HL 转基因兔中 apoA-I 的 FCR 是野生型兔的两倍。

结论

在体内,(1)无脂 apoA-I 迅速掺入预先存在的α迁移颗粒中,(2)前β迁移盘状 HDL 迅速转化为α迁移 HDL,(3)apoA-I 的 FCR 与其引入血浆的形式无关,并且(4)HL 减小了α迁移 HDL 的大小并增加了 apoA-I 的分解代谢率。

相似文献

1
Metabolism of apoA-I as lipid-free protein or as component of discoidal and spherical reconstituted HDLs: studies in wild-type and hepatic lipase transgenic rabbits.载脂蛋白A-I作为无脂蛋白质或盘状及球状重组高密度脂蛋白成分的代谢:野生型和肝脂肪酶转基因兔的研究
Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1912-7. doi: 10.1161/01.atv.0000038485.94020.7f.
2
Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit.家兔中同时含有载脂蛋白A-I和A-II的高密度脂蛋白的形成。
J Lipid Res. 2006 Jan;47(1):115-22. doi: 10.1194/jlr.M500284-JLR200. Epub 2005 Oct 12.
3
Evidence that endothelial lipase remodels high density lipoproteins without mediating the dissociation of apolipoprotein A-I.有证据表明,内皮脂肪酶可重塑高密度脂蛋白,而不介导载脂蛋白A-I的解离。
J Lipid Res. 2005 May;46(5):896-903. doi: 10.1194/jlr.M400212-JLR200. Epub 2005 Feb 1.
4
Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I.前β迁移的低脂载脂蛋白A-I的形成与代谢。
Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):421-8. doi: 10.1161/01.ATV.0000104029.74961.f5. Epub 2003 Oct 30.
5
Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation.经脂解修饰的富含甘油三酯的高密度脂蛋白会迅速从循环系统中清除。
Arterioscler Thromb Vasc Biol. 2002 Mar 1;22(3):483-7. doi: 10.1161/hq0302.105374.
6
Effects of intravenous infusion of lipid-free apo A-I in humans.无脂载脂蛋白A-I静脉输注对人体的影响。
Arterioscler Thromb Vasc Biol. 1996 Sep;16(9):1203-14. doi: 10.1161/01.atv.16.9.1203.
7
In vivo evidence for both lipolytic and nonlipolytic function of hepatic lipase in the metabolism of HDL.肝脏脂肪酶在高密度脂蛋白代谢中脂解和非脂解功能的体内证据。
Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):793-800. doi: 10.1161/01.atv.20.3.793.
8
Evidence that apolipoprotein A-I facilitates hepatic lipase-mediated phospholipid hydrolysis in reconstituted HDL containing apolipoprotein A-II.载脂蛋白A-I促进含载脂蛋白A-II的重组高密度脂蛋白中肝脂酶介导的磷脂水解的证据。
Biochemistry. 2001 May 8;40(18):5496-505. doi: 10.1021/bi0016671.
9
The charge and structural stability of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles.载脂蛋白A-I在盘状和球状重组高密度脂蛋白颗粒中的电荷与结构稳定性
J Biol Chem. 1992 Dec 25;267(36):25839-47.
10
The conformation of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. 13C NMR studies of lysine ionization behavior.载脂蛋白A-I在盘状和球状重组高密度脂蛋白颗粒中的构象。赖氨酸电离行为的13C核磁共振研究。
J Biol Chem. 1992 Dec 25;267(36):25830-8.

引用本文的文献

1
High-Density Lipoprotein Metabolism and Function in Cardiovascular Diseases: What about Aging and Diet Effects?高密度脂蛋白代谢与心血管疾病的功能:衰老和饮食的影响如何?
Nutrients. 2024 Feb 26;16(5):653. doi: 10.3390/nu16050653.
2
Very low HDL levels: clinical assessment and management.极低的高密度脂蛋白水平:临床评估和管理。
Arch Endocrinol Metab. 2023 Jan 18;67(1):3-18. doi: 10.20945/2359-3997000000585.
3
High-density lipoproteins, reverse cholesterol transport and atherogenesis.高密度脂蛋白、胆固醇逆向转运与动脉粥样硬化形成。
Nat Rev Cardiol. 2021 Oct;18(10):712-723. doi: 10.1038/s41569-021-00538-z. Epub 2021 Apr 8.
4
APOA1: a Protein with Multiple Therapeutic Functions.载脂蛋白 A1:具有多种治疗功能的蛋白质。
Curr Atheroscler Rep. 2021 Feb 16;23(3):11. doi: 10.1007/s11883-021-00906-7.
5
Oxidation of methionine residues in human apolipoprotein A-I generates a potent pro-inflammatory molecule.蛋氨酸残基在人载脂蛋白 A-I 中的氧化产生了一种强效的促炎分子。
J Biol Chem. 2019 Mar 8;294(10):3634-3646. doi: 10.1074/jbc.RA118.005663. Epub 2019 Jan 11.
6
Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early- Versus Late-Stage Atherosclerosis.载脂蛋白A-I在动脉粥样硬化早期和晚期的显著不同的抗动脉粥样硬化作用
JACC Basic Transl Sci. 2018 May 30;3(2):187-199. doi: 10.1016/j.jacbts.2017.11.004. eCollection 2018 Apr.
7
Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins.重新思考胆固醇逆向转运和功能失调的高密度脂蛋白。
J Clin Lipidol. 2018 Jul-Aug;12(4):849-856. doi: 10.1016/j.jacl.2018.04.001. Epub 2018 Apr 12.
8
Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation.蛋氨酸氧化载脂蛋白 A-I 在 HDL 生成和淀粉样纤维形成的交汇点处发挥作用。
FASEB J. 2018 Jun;32(6):3149-3165. doi: 10.1096/fj.201701127R. Epub 2018 Jan 17.
9
ABCA1-Derived Nascent High-Density Lipoprotein-Apolipoprotein AI and Lipids Metabolically Segregate.源自ATP结合盒转运蛋白A1(ABCA1)的新生高密度脂蛋白-载脂蛋白AI和脂质在代谢上相互分离。
Arterioscler Thromb Vasc Biol. 2017 Dec;37(12):2260-2270. doi: 10.1161/ATVBAHA.117.310290. Epub 2017 Oct 26.
10
Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization.载脂蛋白A-I肽的给药途径和脂化对药代动力学及胆固醇转运的影响。
J Lipid Res. 2017 Jan;58(1):124-136. doi: 10.1194/jlr.M071043. Epub 2016 Nov 23.